POPULARITY
10 episodes with scai
6 episodes with scai
16 episodes with scai
4 episodes with scai
2 episodes with scai
2 episodes with scai
3 episodes with scai
2 episodes with scai
3 episodes with scai
Hosts Mitsuaki Sawano, MD, and Nobuhiro Ikemura, MD, welcome Yoshitaka Kimura, MD, PhD, of Leiden University Medical Center, to discuss proactive ablation strategies in patients with repaired Tetralogy of Fallot (rTOF). Dr. Kimura presents data from a long-term, single-center study evaluating electroanatomical mapping and preventive ablation of slow-conducting anatomical isthmuses (SCAI) in rTOF patients without prior ventricular tachycardia (VT). The findings show that identifying and successfully ablating SCAI significantly reduced VT incidence, with all VT events occurring in patients where ablation failed. Moreover, this approach reduced the proportion of patients qualifying for ICD implantation from 25–51% under current guidelines to just 11%. Dr. Kimura underscores a paradigm shift in congenital heart disease management—from treating VT reactively to preventing it proactively—highlighting the value of data-driven, tailored care strategies that avoid unnecessary device implantation and better target high-risk individuals.
When Jae's mother faced amputation due to Critical Limb Ischemia (CLI) an advanced stage of Peripheral Artery Disease (PAD) in rural Louisiana, she refused to accept it as the only option. Despite being told there were no alternatives, Jae discovered the truth: not all PAD specialists have the skills to treat advanced cases. This episode comes at a crucial time. A May 2025 study from @SCAI reveals Black patients with CLI face a 46% higher chance of amputation and are 10% less likely to see vascular specialists before treatment. CLI is more deadly than breast, colon, and prostate cancer COMBINED—and outcomes worsen dramatically after amputation. Listen as Jae shares how she: • Fought against medical gaslighting • Found help through the @GlobalPADAssociation's Leg Saver Hotline (1-833-PAD-LEGS) • Connected with CLI specialist Dr. Amit Amin who successfully opened her mother's arteries This story could save someone's leg—or life. Share widely. #SaveALeg #PADAwareness #HealthcareEquity #CLI #PeripheralArteryDisease #PatientAdvocacy
In this inspiring episode of Parallax, Dr Ankur Kalra engages with Dr Srihari S. Naidu, current President of the Society for Cardiovascular Angiography and Interventions (SCAI) and tenured professor at New York Medical College. Their conversation explores Dr Naidu's compelling journey from his formative years and family influences to his strategic vision for elevating interventional cardiology's national profile. Dr Naidu shares his innovative "LINK" philosophy—Leadership, Innovation, Networking, and Knowledge—which has guided his approach to medicine and leadership. The discussion delves into SCAI's remarkable growth in education, publications, and advocacy under his stewardship, while addressing the critical need to increase public understanding of interventional cardiologists' life-saving contributions to healthcare. The conversation offers valuable insights on career progression in medicine, exploring the delicate balance between knowledge and wisdom across different career stages. Dr Naidu provides thoughtful perspectives on the "sweet spot" of mid-career practice, the importance of cross-generational learning, and SCAI's commitment to fostering diversity by removing barriers for women and underrepresented groups in the field. Essential listening for cardiologists at all career stages, healthcare leaders, and those interested in the evolving landscape of interventional cardiology and its impact on patient care and public health. Buy the SCAI Cap here. (https://shop.scai.org/) Questions and comments can be sent to "podcast@radcliffe-group.com" and may be answered by Ankur in the next episode. Host: @AnkurKalraMD and produced by: @RadcliffeCardio Parallax is Ranked in the Top 100 Health Science Podcasts (#48) by Million Podcasts.
Today, we are joined by Bob Gerard.Bob Gerard is a seasoned learning industry professional with over 30 years of experience. At Accenture, he leads the Learning Ingenuity team within the Human Resources organization, focusing on research and development to enhance employee learning. Additionally, he co-hosts The Learning Geeks podcast, which reaches a global audience of learning professionals.In this episode, we explore the science of effective corporate learning and how organizations can measure its true impact on business performance. Bob shares insights from Accenture's billion-dollar annual investment in learning and reveals the research-backed principles that make learning stick.Key topics include:• The SCAI framework for measuring learning impact: Satisfaction, Knowledge, Application, and Impact• Eight durable learning principles that create lasting behavioral change• How immersion neuroscience technology validates effective learning design• The future of personalized, AI-powered learning experiencesLearn from Bob Gerard how to create learning experiences that go beyond attendance metrics to deliver measurable business outcomes, while balancing scientific rigor with practical application in today's rapidly changing workplace.Bob Gerard's LinkedIn: https://www.linkedin.com/in/bob-gerardLearning Geeks Podcast: https://learninggeekspod.comBob's Star Wars Podcast: https://podcasts.apple.com/us/podcast/short-for-a-stormtrooper-a-15-minute-star/id1744259146- Website and live online programs: http://ims-online.com Blog: https://blog.ims-online.com/ Podcast: https://ims-online.com/podcasts/ LinkedIn: https://www.linkedin.com/in/charlesagood/ Twitter: https://twitter.com/charlesgood99Chapters: (00:00) Introduction(01:05) From Computer Science to Learning Expert (04:35) Learning Culture at Accenture (08:50) Tool: The SCAI Measurement Framework (18:55) Tool: Immersion Neuroscience in Learning (25:05) Tool: Eight Durable Learning Principles (34:35) Technique: Learning in the Flow of Work (39:45) Tip: Gaps in Corporate Learning Today (41:25) Tool: AI-Powered Learning Assistants (46:25) Conclusion
If you thought ARDS was a long episode... get ready for a marathon! This week on Critical Care Time, Cyrus and Nick take on the unenviable task of trying to cover everything you need to know about cardiogenic shock - at least in broad strokes - in ONE episode! That's right, this is your one-stop-shop for all things cardiogenic shock. While we will have some deep dives on RV and LV failure, as well as ECMO and other mechanical circulatory support options - this episode has a little bit of it all to wet your whistle and then some! We deconstruct the epidemiology of cardiogenic shock, do a deep dive on the SCAI classes of cardiogenic shock, talk pathophysiology (duh!) and then move on to treatment considerations - both medical and mechanical - followed finally by some cases to cement all the learning. We know this is a long one so feel free to listen/watch in chunks. However you decide to enjoy it, we are certain you will walk away from it ready to conquer the next CGS case you come across! Once you've finished this epic - leave us a review and let us know how we did! Hosted on Acast. See acast.com/privacy for more information.
This week we celebrate the life and career of Dr. Charles Mullins who passed this past week. Dr. Mullins was Professor of Pediatrics at Baylor College of Medicine and one of the pioneers in the world of congenital heart interventional cardiology. In today's episode we will listen back to an episode from 2021 from the SCAI 2021 meeting in which we interviewed Dr. Mullins and Dr. Julie Vincent (then Professor of Pediatrics at Columbia University). Drs. Mullins and Vincent discuss their lives as interventional cardiologists and also speak about the role that mentorship played in their long careers. Dr. Aimee Armstrong of Nationwide Children's Hospital also participates in this conversation. Following this interview replay with Drs. Mullins and Vincent, we speak with Dr. Frank Ing who is the Director of Pediatric Cardiology at UC Davis and the former director of the catheterization lab at Texas Children's and a former trainee and close friend of Dr. Mullins and his family. Dr. Ing shares his memories of training under Dr. Mullins, his thoughts on what was possibly Dr. Mullins' greatest professional contribution and finally speaks about what he learned about being a good mentor from his years with Dr. Mullins.
Interested in setting up an Ambulatory Surgery Center (ASC) or Outpatient Based Lab (OBL)? Special guest Kristen Richards sits down with host Dr. Aaron Fritts to discuss the importance of establishing and tracking safety and quality metrics in the outpatient space to achieve success. Kristen is Vice President of Ambulatory Care at Cardiovascular Logistics in Chicago, IL. --- This podcast is supported by: Philips Image Guided Therapy Solutions https://www.usa.philips.com/healthcare/solutions/image-guided-therapy/all-products --- SYNPOSIS Kristen shares insights from her experience in the cardiovascular ambulatory space, highlighting the necessity of patient safety, efficient care, and the benefits of outpatient settings over hospital environments. Patient selection, infection control, staff and physician satisfaction, economic drivers, and the future outlook for cardiovascular procedures in ASCs are some of the key topics discussed. Kristen also emphasizes the need for continuous data tracking to demonstrate and improve the quality of care provided in these centers. --- TIMESTAMPS 00:00 - Introduction 06:25 - Benefits of Out-of-Hospital Care 17:47 - Financial Incentives and Ownership Models 18:17 - Technological Advancements and Cost Reduction 25:00 - Considerations for Opening an ASC 31:58 - Importance of Quality Metrics --- RESOURCES BackTable VI Podcast Episode #366 Navigating OBL & ASC Business: Pitfalls to Avoid with Teri Yates https://www.backtable.com/shows/vi/podcasts/366/navigating-obl-asc-business-pitfalls-to-avoid BackTable VI Podcast Episode #431 OBL or ASC for Your Private Practice? How to Decide with Teri Yates https://www.backtable.com/shows/vi/podcasts/431/obl-or-asc-for-your-private-practice-how-to-decide BackTable VI Podcast Episode #431 OBL or ASC for Your Private Practice? How to Decide with Teri Yates https://www.backtable.com/shows/vi/podcasts/486/winning-the-revenue-cycle-game Outpatient Endovascular and Interventional Society (OEIS) 2025 Conference: https://oeisweb.com/ Cardiovascular Business: https://cardiovascularbusiness.com/ SCAI: https://scai.org/
AEM # 115 Giles Moffat Boarding School Survivors Taking Their Schools To CourtHow do you take your school to court? How do you get a prosecution for sexual and physical abuse when no one else has listened?A fascinating conversation today with Giles Moffat about how a group of child abuse survivors took their schools to court.Giles talks about how he connected with Nicky Campbell, the BBC DJ, who attended the same school as him.Gradually they built a large network of survivors who managed to get not only the police but also the schools and courts to listen.A very powerful and inspiring conversation.---Giles became a boarder at the Edinburgh Academy in 1980, where he was abused like many others.In 2022 Giles formed the EA Survivors group with Nicky Campbell. Today he shares his insights into effective campaigning and the power of survivor groups.Questions for Giles:I would love for you to share some of your journey. How did you get into the work you are now doing?What were your boarding school experiences like?How did boarding school impact you as an adult?- naming perpetrators and the legalities around that (basically, go for it. We named several people in the media because of their age and have yet to receive a single legal letter in 2 years)Understanding UK defamation law (I have a qualification in this)Influencing prosecution (we lobbied the police and crown office and got 6 arrests in December 23)The experience of giving evidence in court situations The therapeutic and empowering benefits of speaking upWhat motivates survivors when they campaignHow to engage with the authorities and get the best out of them. Working with the media to achieve your aims.Planning and strategy for survivor groups. Historical cover-ups. You have worked in positions of leadership. How did your boarding school education impact the way you lead?Boarding school leaders: Could you please speak to those leaders who have been to boarding school. David Cameron, Boris Johnson. What do you feel about their leadership?What is the work that you are doing now?#childabuse #childhoodtrauma #nickycampbell #edinburghacademy To connect with the survivors group: https://easurvivors.info/For Seen and Heard: https://seenheard.org.uk/--- Piers is an author and a men's transformational coach and therapist who works mainly with trauma, boarding school issues, addictions and relationship problems. He also runs online men's groups for ex-boarders, retreats and a podcast called An Evolving Man. He is also the author of How to Survive and Thrive in Challenging Times. To purchase Piers first book: https://www.amazon.co.uk/How-Survive-Thrive-Challenging-Times/dp/B088T5L251/ref=sr_1_1?dchild=1&keywords=piers+cross&qid=1609869608&sr=8-1 For more videos please visit: http://youtube.com/pierscross For FB: https://www.facebook.com/pierscrosspublic For Piers' website and a free training How To Find Peace In Everyday Life: https://www.piers-cross.com/community Many blessings, Piers Cross http://piers-cross.com/
In this episode, experts discuss a crucial 2024 document outlining appropriate use criteria for multimodality imaging in cardiovascular evaluation before non-emergent non-cardiac surgery, addressing the rising annual surgeries and associated cardiac risks. They delve into balancing the necessity of imaging with cost-effectiveness while exploring the potential of artificial intelligence to enhance future evaluations.
Commentary by Dr. Valentin Fuster
Commentary by Dr. Abdullah Al-Abcha and Dr. Emmanouil S. Brilakis
Host Shelley Wood sums up some top news from SCAI, ESC-HF, ESOC, HRS, and EuroPCR, with takeaways from Thomas Cuisset.
Le prime pagine dei principali quotidiani nazionali commentate in rassegna stampa da Davide Giacalone. Il DEF leggero, la strage nella centrale idroelettrica, le nonne del clima. #ilpostinfabbrica. Oggi con il gruppo di aziende informatiche SCAI, nata a Torino e oggi con sedi in tutta Italia. In studio Paola Zedda, HR manager di SCAI. Don Antonio Mazzi, fondatore della comunità Exodus, regala ogni giorno un pensiero, un suggerimento, una frase agli ascoltatori di RTL 102.5. Il segretario generale della UIL, Pierpaolo Bombardieri, è intervenuto per parlare dell'incidente alla centrale Enel, del lago di Suviana, e delle morti sul lavoro, che sono una strage continua. Con il presidente di Assoutenti, Gabriele Melluso, siamo tornati a parlare ella corsa del prezzo dei carburanti che non si ferma. Al servito siamo oltre 2,1 euro e anche nella fascia low cost (pompe bianche e self) si sfiorano i 2 euro. Le associazioni dei consumatori, come Assoutenti, segnalano punte di distributori già oltre i 2,5 euro per la benzina su alcune aree autostradali. Il giornalista e conduttore Paolo Del Debbio, in libreria con "In nome della libertà" (edito da Piemme), sulla figura di Silvio Berlusconi. All'interno di Non Stop News, con Enrico Galletti, Giusi Legrenzi e Valentina Iannicelli.
September is recognized as Peripheral Artery Disease (PAD) Awareness Month. PAD, a circulatory condition that affects an estimated 8.5 million in the U.S., is often an underdiagnosed condition. However, through early detection/screening this condition can be treated when appropriately indicated through Peripheral Vascular Intervention (PVI). Peer Review is one way to ensure patient care and safety for appropriate diagnosis and treatment options. Safeguarding the patients involves the impartial evaluation by experienced professionals, a comprehensive approach that encompasses proper training/credentialing, adherence to protocols, and a commitment to patient-centered care.Through Corazon's Peer Review and Accreditation services and SCAI as a fundamental partner, being proactive in the advancement and seeking proper measures can lead to continuous growth of your program. This safeguard approach is key not only during PAD Awareness Month but every day for the patients treated.Corazon is the national leader in service line development for the heart, vascular, neuroscience, orthopedic, and perioperative specialties. Contact the Service Line Experts today and stay up-to-date with us on LinkedIn!
If you are at all interested in the status of women in medicine and the role of education in addressing gender inequities in the health professions, then you're going to love today's episode. I'm speaking with Rebecca Ortega about improving gender equity in cardiology. Rebecca is the Founding and executive director of Women as One, a nonprofit organization dedicated to promoting talent in medicine by offering professional opportunities to women cardiologists through several different programs. 1. Rapid Evolution in Cardiology: Rebecca discusses her experience at SCAI, where she was in charge of education. 2. The Art of Grant Writing: Needs assessment in grant writing. Get clear on why a program is necessary and how it will solve a problem. 3. Challenges in Procedural Training: It might be straightforward to offer training for new procedures but gender equity is a more complex challenge that requires a different educational approach.4. Women as One Initiative: This organization promotes gender equity in cardiology through various programs like CLIMB, Escalator Awards, and a talent directory to help diversify clinical trial leadership.5. Future of Gender Equity in Cardiology: Focus on improving the quality of experience for women in the field rather than just numerical representation.Resources
In this episode, Dr. Zanotti discusses advances in the management of cardiogenic shock. His guest is Dr. Jacob Jentzer, a cardiac intensivist trained in both Cardiology and Critical Care Medicine who practices full-time in the Cardiac Intensive Care Unit at Mayo Clinic in Rochester, MN. As the Director of Cardiac Intensive Care Unit Research at Mayo Clinic, he is active in Intensive Care Unit patient outcomes research, with a particular focus on the outcomes of patients with cardiogenic shock and cardiac arrest. Additional Resources Concise Definitive Review: Advances in the Management of Cardiogenic Shock. Jentzer JC et al. Crit Care Medicine 2023: https://pubmed.ncbi.nlm.nih.gov/37184336/ SCAI clinical expert consensus statement on the classification of cardiogenic shock. Baran DA, et al.: https://www.ncbi.nlm.nih.gov/pubmed/31104355 SCAI stages of cardiogenic shock stratify mortality risk. Jentzer JC et al.: https://www.ncbi.nlm.nih.gov/pubmed/?term=SCAI+stages+of+cardiogenic+shock+stratify+mortality+risk Advances in the Staging and Phenotyping of Cardiogenic Shock: Part 1. Jentzer JC, et al. JACC Advances 2022: https://www.jacc.org/doi/10.1016/j.jacadv.2022.100120 Machine Learning Approaches for Phenotyping in Cardiogenic Shock and Critical Illness: Part 2. Jentzer JC, et al. JACC Advances 2023: https://www.jacc.org/doi/10.1016/j.jacadv.2022.100126 Extracorporeal Life Support in Infarct-Related Cardiogenic Shock. ECLS-SHOCK Investigators. New Eng J of Med 2023: https://pubmed.ncbi.nlm.nih.gov/37634145/ Book Recommendations: The Hobbit by JRR Tolkien: https://bit.ly/44S0tZD The Lord of the Rings Trilogy by JRR Tolkien: https://bit.ly/45Q9NP0 The House of God. By Samuel Shem: https://bit.ly/48gnusc
In this week's Parallax, Dr Ankur Kalra's guest is Dr Mirvat Alasnag. Dr Alasnag is an interventional cardiologist at King Fahad Armed Forces Hospital (KFAFH) in Saudi Arabia. Additionally, she serves as the Editor-in-Chief at Current Cardiovascular Imaging Reports and is a member of the Board of Trustees at SCAI. Dr Alasnag and Dr Kalra provide a comprehensive review of the key highlights from ESC Congress 2023. Dr Alasnag distills the background and latest evidence from key interventional trials, emphasizing their significance for patient care. Tune in to discover the strategies that Dr Kalra and Dr Alasnag are currently employing and gain insights into how these data will shape their future decision-making in the catheterization laboratory. Don't miss this informative discussion at the forefront of interventional cardiology. Trials included: FIRE: Physiology-Guided Complete PCI in Older MI Patients MULTISTARS AMI: MULTivessel Immediate Versus STAged RevaScularization in Acute Myocardial Infarction ILUMIEN IV: Optical coherence tomography-guided coronary stent implantation compared to angiography OCTOBER: European Trial on Optical Coherence Tomography Optimized Bifurcation Event Reduction OCT Vs IVUS Vs Angiography Guidance OCTIVUS: Optical coherence tomography non-inferior to intravascular ultrasound for stent guidance What are the take-home messages from ESC 2023 for interventional cardiologists? How can we interpret the results for patient care? What new data have the power to change guidelines? Questions and comments can be sent to “podcast@radcliffe-group.com” and may be answered by Ankur in the next episode. Guests: @mirvatalasnag Host: @AnkurKalraMD and produced by: @RadcliffeCARDIO.
So much has happened since the petition against the ABIM MOC started on 7/21/2023, which is nearing 20,000 signatures. Physicians have called upon their societies and organizations to offer statements on their behalf, but only The Society for Cardiovascular Angiography & Interventions (SCAI) so far has done so. Drs. Srihari Naidu and Allison Dupont, both members and leaders of SCAI, come on the show to explain why they came up with the statement and what it means to the membership. Is there a path forward and why have other societies stayed silent thus far? Drs. Naidu and Allison Dupont offer refreshing opinions as to what might get done and what is to come after the praise that SCAI received. Learn more about the SCAI. https://scai.org/ Check out Chadi's website for all Healthcare Unfiltered episodes and other content. www.chadinabhan.com/ Watch all Healthcare Unfiltered episodes on Youtube. www.youtube.com/channel/UCjiJPTpIJdIiukcq0UaMFsA
At their esteemed 2023 Scientific Sessions Conference held in Phoenix, AZ, the Society for Cardiovascular Angiography and Interventions (SCAI), formally announced a partnership with Corazon. The partnership officially designates Corazon as its preferred accrediting body for cardiovascular programs. This collaboration signals the dawn of a new era, where an unparalleled level of quality oversight will be implemented across cardiovascular care centers throughout the United States.Join Corazon's Amy Newell and Michael Church as they go over key takeaways from this year's conference, as well as what you can expect from the partnership between SCAI and Corazon moving forward. Corazon Accreditation Network Registration: Registration (gotowebinar.com)Corazon Accreditation: Accreditation | Corazon, Inc | Evaluate. Enhance. Excel. (corazoninc.com)SCAI: Home | SCAICorazon is the national leader in service line development for the heart, vascular, neuroscience, orthopedic, and perioperative specialties. Contact the Service Line Experts today and stay up-to-date with us on LinkedIn!
In this week's episode from SCAI 2023, we speak with Professor Kritvikrom Durongpisitikul of Mahidol University, Siriraj Hospital in Bangkok, Thailand about their experience in transcatheter and surgical pulmonary valve replacement (PVR). Who is a candidate for each in the present era? Why was surgery associated with higher mortality rates in this work? Should the criteria for transcatheter PVR differ in comparison with surgery? Dr. Durongpisitikul shares his insights in this live session from SCAI which is co-moderated by Dr. Aimee Armstrong of Children's Nationwide Hospital. https://doi.org/10.1016/j.jscai.2022.100408
Host Shelley Wood catches up with Davide Capodanno and Sunil Rao to hear their highlights from these meetings.
In this week's episode from SCAI 2023, Dr. Aimee Armstrong of Nationwide Children's Hospital joins Dr. Pass in a live session from the annual scientific sessions of SCAI. Professor of Pediatrics at UC Davis, Dr. Frank Ing, reviews his experience with recanalization of central veins in a large pediatric cohort. Who is a candidate for this intervention? When are stents preferred vs. angioplasty alone? Should all patients having central lines removed be evaluated to prevent venous occlusion? What sort of radiation dose is associated with this intervention? Dr. Ing shares his deep knowledge in a live "Pediheart" session from Phoenix, Arizona on 5/19/23 at SCAI 2023. https://doi.org/10.1016/j.jscai.2022.100547
We are LIVE at the Society for Cardiovascular Angiography & Intervention, or SCAI, Conference in Phoenix, Arizona learning about physicians and medical device makers are trying to make procedures safer and improve patient outcomes. One of the technologies we discuss on this episode is an Intravascular Ultrasound, or IVUS, which is an imaging technique that uses a transducer to generate sound waves to produce pictures of the inside of blood vessels. Physicians are mainly using this device during angiograms for diagnostic and treatment of coronary artery disease and peripheral artery disease. Guests include David Chalyan, Director of Evidence Transformation and Medical Safety Officer at Philips IGT-Devices and Royal Philips Chief Safety Officer Steve C de Baca.
SCAI consensus document on LAAC, semaglutide/tirzepatide disruption, NSAIDs, and interventional echocardiography are the topics discussed by John Mandrola, MD, on this week's podcast. This podcast is intended for healthcare professionals only. To read a partial transcript or to comment, visit: https://www.medscape.com/twic I. SCAI Consensus Document New Update on Left Atrial Appendage Closure Recommendations https://www.medscape.com/viewarticle/990507 - SCAI/HRS Expert Consensus Statement on Transcatheter Left Atrial Appendage Closure https://doi.org/10.1016/j.jscai.2022.100577 - Transcatheter Left Atrial Appendage Closure Comes of Age https://doi.org/10.1016/j.jscai.2023.100592 - EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion – an update https://doi.org/10.1093/europace/euz258 II. Semaglutide and Tirzepatide Disruption Tirzepatide Powers 'Unprecedented' Weight Loss in Obesity Trial https://www.medscape.com/viewarticle/975061 - Obesity Management in Primary Care https://reference.medscape.com/recap/982874 - The $76 Billion Diet Industry Asks: What to Do About Ozempic? https://www.wsj.com/amp/articles/ozempic-wegovy-mounjaro-weight-loss-industry-89419ecb III. NSAIDs and HF NSAID Use in Diabetes May Worsen Risk for First HF Hospitalization https://www.medscape.com/viewarticle/990642 - Heart Failure Following Anti-Inflammatory Medications in Patients With Type 2 Diabetes Mellitus https://doi.org/10.1016/j.jacc.2023.02.027 IV. Interventional Echocardiography New ASE Guideline on Interventional Echocardiography Training https://www.medscape.com/viewarticle/990520 - Recommendations for Special Competency in Echocardiographic Guidance of Structural Heart Disease Interventions: From the American Society of Echocardiography https://doi.org/10.1016/j.echo.2023.01.014 You may also like: Medscape editor-in-chief Eric Topol, MD, and master storyteller and clinician Abraham Verghese, MD, on Medicine and the Machine https://www.medscape.com/features/public/machine The Bob Harrington Show with Stanford University Chair of Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington Questions or feedback, please contact: news@medscape.net
This week we review a recent report of a new technique to implant SAPIEN valves for transcatheter pulmonary valve replacement in which 1-3 stents are implanted simultaneously with the SAPIEN valve. What are the potential benefits or disadvantages of this approach and who might be a better candidate for this method? Why is a stent needed outside of the relatively strong SAPIEN prosthesis and how does the team in San Diego choose bare metal vs. covered stents when performing this procedure? We speak with pediatric interventional cardiologist Dr. Jessica Heibel of Pediatrix in San Antonio, Texas about a recent work she co-authored with the team at Rady Children's Hospital in San Diego, California. Dr. Heibel reviews many of the finer points of transcatheter valve implantation this week. DOI: https://doi.org/10.1016/j.jscai.2022.100553
The Society for Cardiovascular Angiography and Interventions (SCAI) latest consensus statement deemed that cardiologists CAN safely perform PCI without on-site surgical backup. In this Service Line Podcast, the Corazon team breaks down the significant changes and implications of this consensus statement - the first of its kind since 2014. For more information, visit www.corazoninc.comCorazon is the national leader in service line development for the heart, vascular, neuroscience, orthopedic, and perioperative specialties. Contact the Service Line Experts today and stay up-to-date with us on LinkedIn!
Dr. Ehtisham Mahmud, on behalf of the document leadership team and writing committee for the ACC/AHA/SCAI Interventional Cardiology Advanced Training Statement, presents a high-level overview of the cardiovascular profession's first document covering the breadth of interventional cardiology training, including coronary, peripheral vascular, structural heart, and adult congenital heart interventions.
This week we delve into the world of ACHD when we review a recent work on outcomes of non-cardiac surgery in the ACHD patient. How do ACHD patients fare in comparison to their non-ACHD cohort undergoing non-cardiac surgery? What can be done to improve outcomes in this patient group? We speak with the senior author of this work, Dr. Peyman Benharash, who is Associate Professor of Surgery at UCLA. DOI: 10.1136/heartjnl-2022-321512Also joining us this week is Dr. Alexandra Lansky of Yale University who is also the Editor-in-Chief of JSCAI which is the newest interventional cardiology journal and the official journal of SCAI. Dr. Lansky shares with us her hopes for the new journal and also the role that congenital interventions will play in this journal. Visit JSCAI.org to see what 'all the fuss' is about!
This week we play a session of the podcast from SCAI 2022 in Atlanta with Professor of Pediatrics, Columbia University - Dr. Christopher Petit reviewing a recent publication on the topic of systemic sirolimus in concert with catheter interventions for the treatment of pulmonary vein stenosis. Who is a candidate for this sort of therapy? Does systemic sirolimus confer a survival benefit over local stent delivery? Who should be caring for patients with pulmonary vein stenosis? Who is a candidate for transcatheter intervention vs. surgical intervention? Dr. Petit provides the answers in this live session from SCAI 2022. doi: 10.1016/j.jacc.2021.04.013
This week in a live session from SCAI 2022 we hear Assistant Professor of Pediatrics, Dr. Eimear McGovern shares her insights into a recent work she co-authored on changes in Fontan dimensions over time. Who needed interventions and how does the team in Kentucky choose to perform surveillance catheterizations on their Fontan patients? Is there an optimal time? What degree of stenosis or narrowing of a Fontan deserves intervention? Dr. McGovern provides the answers from Atlanta's SCAI Scientific Sessions on 5.21.22. doi: 10.1007/s00246-021-02658-2.
Procedures & Techniques of PCI. 2021 ACC/AHA/SCAI guidelines. A discussion on Vascular access, stent types, Thrombectomy, CTO PCI, ISR, SVG - PCI, Hemodynamic Support for #PCI and many such topics. We have been discussing the 2021 #coronary revascularization guidelines given by #ACC. This is the 6th and the last video in this series. in this video we discuss about the following Vascular Access Stent types Thrombectomy Intravascular Imaging (IVUS & OCT) Calcified lesion In stent restenosis CTO PCI PCI for patients after CABG (SVG PCI) Hemodynamic Support for PCI In order to learn more about Vascular Access, Stent types, Thrombectomy, Intravascular Imaging (IVUS & OCT), treatment of Calcified lesion, In stent restenosis, CTO PCI, PCI for patients after CABG (SVG PCI), Hemodynamic Support for PCI watch the video. A discussion on guidelines given by the following bodies. #americanheartassociation #acc2021 #scai Related and recommended video In stent restenosis https://youtu.be/4poE6E5yZJc Revascularization in stable CAD -1 https://youtu.be/ZIxUpDY32MQ Revascularization in stable CAD -2 https://youtu.be/fyHM6KJ9B_M Revascularization in NSTE- ACS https://youtu.be/hul1sRuxezg Revascularization in STEMI https://youtu.be/SknUePl9KzQ Antiplatelet Therapy before, during & after Revascularization https://youtu.be/YUI6C9XHyyo Revascularization in special situations https://youtu.be/5e6rox6oJ2A This was a complete discussion on the recommendations from: American Heart Association American College of Cardiology. Society for Cardiovascular Angiography and Interventions.
ANTIPLATELET THERAPY BEFORE / DURING & AFTER PCI and CABG - 2021 ACC/AHA/SCAI GUIDELINES. A lot has changed in the field of Antiplatelet and antithrombotic therapy in patients undergoing #PCI or CABG. New evidence from trials like TWILIGHT trial, STOPDAPT trial, GLASSY & GLOBAL LEADER trial has made us reconsider what is optimal Antiplatelet Therapy for patients undergoing CABG and PCI. The new ACC/ AHA/ SCAI Guidelines have considered these evidence and have given new recommendations for patients undergoing #coronary revascularization. Let's take a deep dive into the topic. We have discussed 2021 ACC/AHA/SCAI GUIDELINES under various headings in the following videos and podcast. Do have a look. Revascularization in STEMI https://youtu.be/SknUePl9KzQ Revascularization in NSTE-ACS https://youtu.be/hul1sRuxezg Revascularization in stable CAD https://youtu.be/fyHM6KJ9B_M
Revascularization in special situations - #pregnancy, old age, chronic kidney disease, cardiac allograft; revascularization to prevent ventricular tachycardia. Here is a discussion from 2021 ACC/AHA/SCAI GUIDELINES on Myocardial Revascularization. What to do in case of pregnancy? What to do in patients with #CKD? What to do in patients with old age? What to do in patients with ventricular tachycardia? What to do in patients with spontaneous #coronary artery dissection #SCAD? What to do in patients with cardiac allograft? This video and Podcast answer the appropriate revascularization modality in patients with pregnancy, old age, chronic kidney disease, cardiac allograft and ventricular tachycardia. This podcast is part of lectures we are doing on 2021 ACC/AHA/SCAI GUIDELINES on Myocardial Revascularization. Related discussions: Antiplatelets before/ during & after Revascularization. https://youtu.be/YUI6C9XHyyo Revascularization in STEMI https://youtu.be/SknUePl9KzQ Revascularization in NSTE-ACS https://youtu.be/hul1sRuxezg Revascularization in stable CAD https://youtu.be/fyHM6KJ9B_M Cardio Ed podcast is available on all major podcast platforms. Do follow and share the podcast and videos.
Coffee and Cardiology with Interventional Cardiologist Dr. Jamie McCabe to talk about what it takes to complete 150 mitraclip procedures, redefining how outcomes are measured, what leadership means to him and his crossroads between furniture making and medicine.2:57 - Mitraclip5:30 - Structural Heart Team7:05 - Dynamics of multidisciplinary teams9:40 - Volumes (Both sides)16:40 - TAVR Returns19:00 - TAVR Patient Selection 22:10 - Physician Report Cards25:00 - Risk Treatment Paradox29:40 - Leadership philosophy 33:45 - Vision of the Cath lab37:23 - Impact of Covid41:06 - Outside of the Lab42:43 - The furniture maker?49:08 - The pinnacle of structural heartDr. James (Jamie) McCabe grew up in Boston, Massachusetts, graduated magna cum laude from Bowdoin College and received his medical degree from Yale University. He has completed 10 years of post-medical school training including internal medicine training and general cardiology fellowship at University of California, San Francisco (UCSF) and interventional cardiology fellowship as well as an advanced interventional fellowship in structural and peripheral treatments at Brigham and Women's Hospital / Harvard Medical School. He is board certified in Internal Medicine, Cardiology, and Interventional Cardiology.Dr. McCabe joined the University of Washington Medical Center in 2013. He became medical director of the Cardiac Cath Labs in 2015 and subsequently was named Chief of Interventional Cardiology for the UW System in 2020. His clinical practice leverages his knowledge and experience in clinical cardiovascular medicine and complex coronary and valvular heart interventions. Dr. McCabe is an international leader in structural heart interventions including repair or replacement of all heart valves using catheter-based methods. He also treats all forms of coronary artery blockage and cardiogenic shock. He is an internationally recognized clinician educator and investigator in transcatheter therapies for valvular heart disease. His research interests focus on quality and performance metrics for cardiovascular procedures and novel transcatheter therapies to address unmet needs in the structural heart space. He has been the site principal investigator for dozens of clinical trials and has authored more than 100 original manuscripts and multiple book chapters related to his work. He lectures frequently at national and international meetings including at Transcatheter Cardiovascular Therapeutics (TCT), Trancatheter Valve Therapeutics (TVT), American College of Cardiology (ACC) and Society for Cardiac Angiography and Intervention (SCAI), amongst others. He has also been asked to perform live televised procedures for national and international audiences across multiple continents. He has been recognized as an Emerging Leader in Medicine by SCAI and the ACC, named one of three finalists for the Linnemeier Award, and voted a “Top Doc” in cardiology multiple years in a row by Seattle Magazine and Seattle Met Magazine.To reach Dr. Jamie McCabe you can email him at jmmccabe@uw.edu.Or send a referral or consult request here: https://hipaa.jotform.com/uwheart/referrals
Revascularization in stable CAD. ACC/AHA/SCAI guidelines 2021. Revascularization in stable CAD (coronary artery disease) had been a matter of debate in the field of Interventional Cardiology and cardiac surgery. What to do in patients with single vessel disease? What to do in patients with triple vessel disease? What to do in patients with Diabetes? Should the patients receive medical treatment only? Should the patients be managed by stenting? Should the patients be managed by CABG? This was a huge 100+ page document, so breaking it down for easier discussion into multiple parts. This is third of many videos about to come on this document by ACC/AHA/SCAI. #Coronary #AHA2021 #americanheartassociation current evidence in the stable CAD - #ISCHEMIA trial, #FREEDOM trial, #ORBITA trial, #COURAGE trial and many other such trials. we had previously discussed revascularization in stable CAD & various studies related to it in this video. Revascularization in stable CAD-1 https://youtu.be/ZIxUpDY32MQ #cardiology #CardioEd #cardiacsurgery #CardiacSurgeon #ischemiatrial Follow Cardio-Ed for more content. https://m.youtube.com/channel/UCVxInTblTpoy-THMuSxNyvw/videos AVATAR trial. https://youtu.be/yVy2muQkOyA REVERSE IT trial https://youtu.be/gdQHuA0mT3E Revascularization in stable CAD https://youtu.be/ZIxUpDY32MQ Half dose DOAC vs standard antithrombotic therapy after LAA occlusion https://youtu.be/6xd6G2ieIWU ISCHEMIA trial and contemporary PCI practice in US https://youtu.be/DnUdv5-q9Ts FAME 3 trial. https://youtu.be/3x6qNXhNlko ACTIVATION trial https://youtu.be/cA75MKO_Ha8 EMPEROR PRESERVED trial https://youtu.be/Zq4fprAcQPI Treatment of HFpEF https://youtu.be/M9os7eYNI20 The role of SGLT2 Inhibitors in this video. SGLT2inhibitors in heart failure. https://youtu.be/T5Zhof_6-3Q Device related thrombosis after LAA occlusion https://youtu.be/ghSvuGsK06k Abelacimab for prevention of venous thromboembolism https://youtu.be/2_gaHMTz2T8 ADAPTABLE trial. Aspirin for secondary prevention https://youtu.be/94lhXi3nQUs REHAB-HF trial. Cardiac rehabilitation in heart failure https://youtu.be/EMyiA-KrbP0 GALACTIC HF trial. Omecamtiv mecarbil in heart failure https://youtu.be/H7F42lhe5ao In-stent restenosis https://youtu.be/4poE6E5yZJc TTM-2 trial. Therapeutic hypothermia in cardiac arrest https://youtu.be/FKdvKcr8bEs FLOWER-MI trial. FFR in STEMI https://youtu.be/ijJRqgbda4Q LAAOS-3 trial. Left atrial appendage occlusion in cardiac surgery https://youtu.be/mc4j7mLw22Q Cardio-Ed is now available on Apple Poscast, Google Podcast, Spotify and other major podcast platforms too. Now you can stay updated on the go. Listen to episodes.(New episodes should be immediately avaliable on Spotify; would feature on other platforms in a while). Here are the links. Apple https://podcasts.apple.com/us/podcast/cardio-ed/id1570745864 Google Podcast https://podcasts.google.com/feed/aHR0cHM6Ly9hbmNob3IuZm0vcy81ZDRiOTgwMC9wb2RjYXN0L3Jzcw Spotify: https://open.spotify.com/show/3SLQ2g4Ii8hdFiy7i8LMRp?si=hWgPgwliQ5a5RY_nz-Q22g&utm_source=copy-link Amazon Music https://music.amazon.in/podcasts/4215cfdf-5121-438e-b355-14eaabed41e5/CARDIOED?ref=dm_sh_vn5xvDArGZGRCTh8YpK3Mdtff Stitcher: https://www.stitcher.com/podcast/cardioed Podcastaddict: https://podcastaddict.com/podcast/3368070 Breaker: https://www.breaker.audio/cardio-ed PocketCasts https://pca.st/bprb5899 RadioPublic https://radiopublic.com/cardioed-Woje3A Podcast Index https://podcastindex.org/podcast/3933141 Player FM https://player.fm/series/cardio-ed Listen Notes https://www.listennotes.com/podcasts/cardio-ed-cardio-ed-Jk3r1sq5_VF/
Revascularization in NSTE- ACS (Non ST segment elevation acute coronary syndrome). 2021 ACC/AHA/STS/SCAI guidelines for myocardial revascularization -2. A discussion on every old and new concept in 2021 guidelines for myocardial revascularization. This was a huge 100+ page document, so breaking it down for easier discussion into multiple parts. This is second of many videos about to come on this document by ACC/AHA/SCAI. #Coronary #AHA2021 #ACC2021 #SCAI2021 #americanheartassociation #americancollegeofcardiology #cardio #cardiology #interventionalcardiology #interventions #NSTEACS #NSTEMI #Unstableangina #myocardialinfarction #meded #cardiovascular
Cardiogenic shock is a state of cardiac dysfunction leading to hemodynamic instability and end-organ hypoperfusion. At the bedside, clinicians take various data points – from history to physical exam to labs/imaging and invasive hemodynamics – to make an assessment of the etiology, severity and management of cardiogenic shock. Health systems have developed “Shock Teams” to collectively interpret this data to deliver the optimal care for each patient. In this episode, Dr. Mark Dela Cruz (Advanced Heart Failure and Transplant Fellow at University of Chicago), CardioNerds Critical Care Series Co-Chairs Dr. Mark Belkin (Advanced Heart Failure and Transplant Fellow at University of Chicago) and Dr. Karan Desai (General Cardiology Fellow at University of Maryland), and CardioNerds Co-Founder Dr. Daniel Ambinder (Structural Fellow at Johns Hopkins Hospital) join Dr. Anu Lala (Director of the AHFT Fellowship, Associate Professor of Medicine and Cardiology at Mount Sinai Hospital and Deputy Editor of the Journal of Cardiac Failure) on a Shock Team Call! Dr. Lala leads us in a discussion of the systematic bedside evaluation of cardiogenic shock, from understanding a patient's physiology and their humanity, to manage their illness and make a rapid but thorough evaluation when on the Shock Call. Audio editing and episode introduction by CardioNerds Academy Intern, Hirsh Elhence. Claim free CME for enjoying this episode! Disclosures: None Pearls • Notes • References • Guest Profiles • Production Team CardioNerds Cardiac Critical Care PageCardioNerds Episode PageCardioNerds AcademyCardionerds Healy Honor Roll CardioNerds Journal ClubSubscribe to The Heartbeat Newsletter!Check out CardioNerds SWAG!Become a CardioNerds Patron! Pearls and Quotes - Shock Team Call The classic definition of cardiogenic shock was derived from studies of left ventricular dysfunction in the setting of acute myocardial infarction. With the advent of early primary percutaneous coronary intervention (PCI) and trends in cardiovascular disease risk factors, the prevalence of non-ischemic etiologies of cardiogenic shock (e.g., progression/exacerbation of chronic heart failure) has increased significantly. The diagnosis of cardiogenic shock should be made by integrating key clinical features such as physical exam findings and objective laboratory and imaging data in an iterative fashion. Focused transthoracic echocardiography and invasive hemodynamics are helpful in further characterizing the type of shock and the etiology of cardiogenic shock. Early evaluation of right ventricular function is an important aspect of cardiogenic shock evaluation. Significant RV dysfunction portends poor prognosis, can necessitate more aggressive interventions, and defines the types of mechanical circulatory support necessary. Classification systems for cardiogenic shock help to further characterize a patient's illness severity. The INTERMACS and SCAI classification systems are particularly designed to allow for early identification of patients who would most benefit from more advanced interventions such as vasoactive medications or mechanical circulatory support. Shock Team Calls improve mortality for patients in cardiogenic shock. By rapidly bringing together heart failure specialists, interventional cardiologists, cardiothoracic surgeons, and critical care physicians, appropriate interventions and contingencies can be discussed and quickly implemented without adding delays to patient care. Importantly, these calls should attempt to integrate patient goals of care in order to best serve our patients. Show notes - Shock Team Call 1. What is the classic definition of cardiogenic shock? The classic definition of cardiogenic shock was initially derived from the Shock Trial published in 1999 (1). In this trial, cardiogenic shock was defined as shock due to left ventricular dysfunction occurring in the setting of acute myocardial infar...
Revascularization in STEMI. 2021 ACC/AHA/STS/SCAI guidelines for myocardial revascularization -I. A discussion on every old and new concept in 2021 guidelines for myocardial revascularization. This was a huge 100+ page document, so breaking it down for easier discussion into multiple parts. This is first of many videos about to come on this document by ACC/AHA/SCAI. #Coronary #AHA2021 #americanheartassociation #cardio #cardiology #interventionalcardiology #interventions #STEMI #myocardialinfarction #meded #cardiovascular
CardioNerds (Amit Goyal and Daniel Ambinder), are joined by guest host Dr. Alex Pipilas (CardioNerds Ambassader, Boston University), and Cleveland Clinic fellows, Dr. Gary Parizher, Dr. Ambreen Ali, and Dr. Tiffany Dong. They discuss a case of an 18-year-old man with Autism Spectrum Disorder presented with advanced nonischemic dilated cardiomyopathy. Due to anxiety, he was unable to tolerate right heart catheterization, and the initial evaluation for advanced heart failure therapies was deferred. With assistance from a multidisciplinary team, catheterization was successful, and he underwent cardiac transplantation. Faculty experts, Dr. Richard Dane Meredith (Cardiovascular Imaging, Mission healthcare), Dr. Julie Niezgoda (Congenital Cardiac Anesthesiologist, CCF), and Dr. Ran Lee (Critical Care Cardiology and Advanced HF/Transplant Cardiologist, CCF) provide the E-CPR for this episode. Audio editing by CardioNerds Academy Intern, Dr. Leticia Helms. Claim free CME just for enjoying this episode! Disclosures: NoneJump to: Pearls - Notes - References CardioNerds Case Reports PageCardioNerds Episode PageCardioNerds AcademyCardionerds Healy Honor Roll CardioNerds Journal ClubSubscribe to The Heartbeat Newsletter!Check out CardioNerds SWAG!Become a CardioNerds Patron! Episode Teaching Pearls - Heart Failure with Autism Spectrum Disorder Autism spectrum disorder should not be regarded as a contraindication to organ transplantation.Respect for patient discomfort with procedures, and efforts to mitigate that discomfort, are essential.A multidisciplinary team approach, especially one utilizing allied health support services, is important to provide care to adolescent patients with advanced organ dysfunction, particularly those with developmental disabilities. Notes - Heart Failure with Autism Spectrum Disorder Autism spectrum disorder (ASD) is a developmental disability characterized by impairments in social interaction and the presence of restricted, repetitive patterns of behaviors, interests, or activities (2). In 2016 the CDC estimated one in 54 children age 8 had ASD (3). Despite ASD's prevalence, studies of organ transplantation in children and adolescents with developmental disabilities are lacking. Guidelines from the International Society for Heart Lung Transplantation indicate that heart transplantation cannot be recommended in patients suffering from severe cognitive-behavioral disabilities (4). However, the definition of “severe” is not clear, so the assessment of severity of a cognitive impairment, as well as whether the impairment constitutes a contraindication to organ transplantation, falls to healthcare providers on a case-by-case basis. Cardiac transplantation in a patient with ASD has been documented previously (5). Nonetheless our case represents an important example of advocacy for lifesaving care in patients with developmental disability. Without any one component of the team taking care of our patient, including physicians and allied healthcare providers, he would have died of refractory cardiogenic shock. However, with individualized care and a multidisciplinary combined effort, his providers were able to overcome the obstacles posed by his ASD and deliver indicated interventions. References - Heart Failure with Autism Spectrum Disorder 1. Baran, David A., et al. "SCAI clinical expert consensus statement on the classification of cardiogenic shock" Catheterization and Cardiovascular Interventions 94.1 (2019): 29-37. 2. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders. 5th edition. Arlington, VA: American Psychiatric Association, 2013. 3. Baio J, Wiggins L, Christensen D, et al. Prevalence of Autism Spectrum Disorder among children aged 8 years - Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, 2014. MMWR Surveillance Summaries 2018; 67:1-23. 4. Mehra M, Canter C,
Inilah ajang buat para petani Indonesia untuk berkompetisi mencari kopi dengan nilai tertinggi dalam event Indonesia Cup of Excellence (COE). Michael Utama, Wakil Ketua Umum SCAI sebagai koordinator COE akan menjabarkan bagaimana event ini akan memberikan keuntungan bagi para petani untuk mendapatkan harga terbaik dan akses akses market yang lebih luas selain kebanggaan buat para petani itu sendiri tentunya.
Returning guest, Dr. Kendra Grubb, surgical director of the Structural Heart and Valve Center at Emory Healthcare in Atlanta discusses Medtronic's announcement of early results from the OPTIMIZE PRO clinical study at the Society for Cardiovascular Angiography & Interventions (SCAI) 2021 Scientific Sessions. The study evaluated procedure-related techniques and care pathways when using the self-expanding, supra-annular Evolut™ PRO and PRO+ TAVR systems in patients with symptomatic severe aortic stenosis. Dr. Kendra Grubb is the surgical director of the Emory Structural Heart and Valve Center. Prior to joining Emory, Dr. Grubb was the director of minimally invasive cardiac surgery and the surgical director of the heart valve program at the University of Louisville. Dr. Grubb is a champion for women's heart disease, and is dedicated to improving the lives of all patients, both male and female, through innovation and by building collaborative teams to promote a patient-centered approach to the treatment of cardiovascular disease.Dr. Grubb has led and participated in multiple clinical trials of innovative cardiac surgery technologies, including studies of transcatheter aortic valve replacement (TAVR), MitraClip percutaneous therapy, and the GORE® conformable TAG® thoracic endoprosthesis for the primary treatment of aneurysms of the descending thoracic aorta.Dr. Grubb attended the University of Southern California, where she received her MD degree from the Keck School of Medicine and her Master of Health Administration from the Sol Price School of Public Policy. She completed her general surgery residency at the University of Illinois at Chicago in 2010, her fellowship in cardiothoracic surgery at the University of Virginia in Charlottesville in 2012, and her fellowship in interventional cardiology and transcatheter therapies at New York Presbyterian/Columbia University Medical Center in 2013. #OPTIMIZEPRO #SCAI #EvolutPRO
Returning guest, Dr. Thomas Jones, Professor of Pediatrics and Adjunct Professor of Medicine at the University of Washington School of Medicine and Director of the Cardiac Catheterization Laboratories at Seattle Children's Hospital and an investigator on the Medtronic Harmony™ Transcatheter Pulmonary Valve (TPV) pivotal trial discusses the one-year outcomes from the Pivotal Trial and 30-day outcomes from the Continued Access Study at a late-breaking session during SCAI (Society for Cardiovascular Angiography & Interventions) Scientific Sessions. The Harmony TPV is the first minimally invasive therapy created to treat patients with a specific type of congenital heart defect of the right ventricle. Thomas K. Jones, MD is a Professor of Pediatrics and Adjunct Professor of Medicine at the University of Washington School of Medicine and the Director of the Cardiac Catheterization Laboratories at Seattle Children's Hospital. Dr. Jones is a graduate of the Jefferson Medical College in Philadelphia. After completing his pediatrics residency at the University of Washington and his pediatric cardiology fellowship training at the University of Colorado and the Denver Children's Hospital, Dr. Jones returned to Seattle where he spent the first 8 years of his career in private practice. In 1991 Dr. Jones helped create the Children's Heart Center at the Seattle Children's Hospital. In the same year he joined the academic faculty of the University of Washington and became the first Director of the Cardiac Catheterization Laboratories at the Seattle Children's Hospital. Seattle Magazine has repeatedly named him among Seattle's Top Doctors. Dr. Jones' lifelong work has focused on congenital and structural interventional cardiac catheterization in children and adults. He has worked to pioneer several less invasive techniques to correct congenital heart conditions. He has authored over 100 manuscripts, book chapters, abstracts and editorials and has participated as an investigator in over 20 multicenter clinical trials in the U.S. Dr. Jones collaborates with emerging technology companies to develop and test new products designed to treat congenital and structural heart conditions. His research interests are currently focused on percutaneous heart valve implantation. He continues to serve on numerous national committees and task forces promoting clinical guidelines and practice standards for patients with congenital heart disease. He is also committed to working with regulatory bodies on novel approval guidelines that will improve patient access to improved cardiovascular devices needed to treat the uncommon conditions that pediatric cardiologists face every day. #SCAI #HarmonyTPVSystem
This week we play a live podcast session from SCAI 2021 (April 30, 2021) on the topic of balloon angioplasty for native aortic coarctation in infants aged 3-12 months. We speak with the senior author of this recent work from Toronto Sick Children's Hospital - Professor Rajiv Chaturvedi. How often were complications encountered? How do results compare with surgical repair? Is high pressure required for these dilations? Professor Chaturvedi provides all the answers and more this week! doi: 10.1161/CIRCINTERVENTIONS.120.008938
This week we speak with Professor Eric Rosenthal of Evelina Children's Hospital in London, England from a session at SCAI 2021. Who is a candidate for closure of a superior sinus venosus ASD in the cath lab and how is this determined? If there is a residual shunt, how much is too much? How did Professor Rosenthal embark on this approach and what have been the results? What percentage of these patients are candidates for this novel approach? This is a rare opportunity to have the author present their own data followed by questions from Dr. Pass and Dr. Aimee Armstrong of Nationwide Children's Hospital. https://doi.org/10.1016/j.jacc.2019.12.070
DREAM ON FLY
This week we have a special treat in playing a session from the SCAI meeting from today, April 29, 2021! We speak with Professor Julie Vincent of Columbia University and Professor Chuck Mullins of Baylor College of Medicine. Both speak about their early lives, how they chose to become physicians and how life in retirement is treating them. What role did teamwork play in each doctors' professional life? How did Dr. Mullins design the 'Mullins sheath'? These are amongst the many topics we touch upon in this 'slice of life' conversation that was recorded today from the 2021 Scientific Sessions of SCAI which continues through May 1, 2021!
As one of our region's most important nonprofits, the Steel City Arts Initiative (SCAI) is a community-based agency dedicated to providing cultural, arts and education programs geared towards empowering school age children and their families. We are excited to welcome SCAI Executive Director Jonnet Solomon to Business as Usual to show us how SCAI engages the community with its rich and diverse programming tailored to promote a sense of determination and accomplishment for all ages. Find out how SCAI has navigated the COVID-19 pandemic and will continue to positively impact the region well into the future.
Episode 006 | October 20, 2020 At Microsoft Research India, research focused on societal impact is typically a very interdisciplinary exercise that pulls together social scientists, technology experts and designers. But how does one evaluate or validate the actual impact of research in the real world? Today, we talk to Tanuja Ganu who manages the Societal Impact through Cloud and AI (or SCAI) group in MSR India. SCAI focuses on deploying research findings at scale in the real world to validate them, often working with a wide variety of collaborators including academia, social enterprises and startups. Tanuja is a Research SDE Manager at Microsoft Research, India. She is currently part of MSR’s new center for Societal impact through Cloud and Artificial Intelligence (SCAI). Prior to joining MSR, she was a Co-Founder and CTO of DataGlen Technologies, a B2B startup that focuses on AI for renewable energy and sustainability technologies. Prior to this, she has worked as Research Engineer at IBM Research, India. Tanuja has completed MS in Computer Science (Machine Learning) from Indian Institute of Science (IISc, Bangalore). She has been recognized as MIT Technology Review’s Innovator Under 35 (MIT TR 35) in 2014 and IEEE Bangalore Woman Technologist of the Year in 2018. Her work was covered by top technical media (IEEE Spectrum, MIT Technology Review, CISCO Women Rock IT TV series, IBM Research blog and Innovation 26X26: 26 innovations by 26 IBM women). Click here to go to the SCAI website. Related Microsoft Research India Podcast: More podcasts from MSR India iTunes: Subscribe and listen to new podcasts on iTunes Android RSS Feed Spotify Google Podcasts Email Transcript Tanuja Ganu: As the name suggests, SCAI, that is Societal Impact through Cloud and Artificial Intelligence, it is an incubation platform within MSR for us to ideate on such research ideas, work with our collaborators like academia, NGOs, social enterprises, startups, and to test or validate our hypothesis through very well defined real world deployments. At SCAI, it's an interdisciplinary team of social scientists, computer scientists, software engineers, designers, and program managers from the lab who come together for creating, nurturing and evaluating our research ideas through real world deployments and validations. [Music] Sridhar: Welcome to the Microsoft Research India podcast, where we explore cutting-edge research that’s impacting technology and society. I’m your host, Sridhar Vedantham. [Music] At Microsoft Research India, research focused on societal impact is typically a very interdisciplinary exercise that pulls together social scientists, technology experts and designers. But how does one evaluate or validate the actual impact of research in the real world? Today, we talk to Tanuja Ganu who manages the Societal Impact through Cloud and AI (or SCAI) group in MSR India. SCAI focuses on deploying research findings at scale in the real world to validate them, often working with a wide variety of collaborators including academia, social enterprises and startups. Tanuja has been recognized as one of MIT Technology Review’s Innovators Under 35 (MIT TR 35) in 2014 and by IEEE Bangalore as a Woman Technologist of the Year in 2018, and her work has been covered by top technical media. [Music] Sridhar Vedantham: Tanuja, welcome to the podcast. I'm really looking forward to this particular edition of what we do here. Because, I know that you manage SCAI and it's quite an intriguing part of the lab. Now before we get into that, tell us a little bit about yourself. Tanuja Ganu: First of all, thanks Sridhar for having me on the podcast today. And uh, yes, uh, I'm not a full-time researcher, but I'm engineer by training and I have done my Master’s in Computer Science. Over the last decade or so, my work is primarily at the intersection of research and engineering, and it's on the applied research side. So throughout my experience and journey, working at research labs and start up, I'm very much interested in taking a research idea through the entire incubation phase to validate its applicability in real world problem settings. Sridhar Vedantham: So, Tanuja, I know you manage this thing called SCAI within the lab and I think it's a very interesting part of the lab. Talk to us a little bit about that, and especially expand upon what SCAI- the term SCAI- itself stands for, because I myself keep tripping up on it whenever I try to explain it. Tanuja Ganu: Yes, Sridhar. So since the inception of our lab, the lab has been doing very interesting work in the societal impact space. Additionally, with the advances in artificial intelligence and cloud-based technologies in recent years there are increased opportunities to address some of these societal problems through technology and amplify its positive effect. So as the name suggests, SCAI, that is Societal Impact through Cloud and Artificial Intelligence, it is an incubation platform within MSR for us to ideate on such research ideas, work with our collaborators like academia, NGOs, social enterprises, startups, and to test or validate our hypothesis through very well defined real world deployments. Also our location in India allows us to witness and carefully analyze various socio-economic challenges. So the solutions that we ideate are inspired by Indian settings and in many cases equally applicable to different parts of the world. Sridhar Vedantham: Interesting, so it sounds like there's a fair amount of difference between the kind of work that SCAI does and between what the rest of the lab actually does in terms of research. Tanuja Ganu: So at MSR India, where research work is mainly along three different axes, firstly advancing the state of the art in science and technology, second is inspiring the direction for technology advances, and the third important axis is building the technology for driving societal impact. So SCAI is primarily focused on social impact access and many of our projects also do have very strong academic and technological impact. At SCAI, it's an interdisciplinary team of social scientists, computer scientists, software engineers, designers, and program managers from the lab who come together for creating, nurturing and evaluating our research ideas through real world deployments and validations. So that's really the difference in terms of the other type of research that we do at lab and what we do at SCAI. Sridhar Vedantham: So when you decide to take up a project or accept it under the SCAI umbrella, what do you actually look for? Tanuja Ganu: Yeah, we look for a few things for defining a SCAI project. So firstly, it should address a significant real-world problem and should have a potential to scale. The second thing is the problem should offer interesting research challenges for our team. The next thing is whether we have credible partners or collaborators with domain expertise to deploy, evaluate and validate of our research. We also look for how we can define rigorous impact evaluation plan for a project. And lastly, we look for what are the feasible graduation paths for the project within two to three years of time horizon. Sridhar Vedantham: What do you mean by graduation? Tanuja Ganu: So, um, there are different ways in which a particular project can complete its successful execution at SCAI center, and that's what we're really terming it as a graduation. And there could be really different types of graduation path depending upon each type of project. Sridhar Vedantham: OK, let's talk a little bit about some of the projects that you are currently doing under the SCAI umbrella. Because to me from what you've said so far, it sounds like there's probably going to be a fairly wide spread of types of projects, and quite a large variety in the type of things that you're doing there. Tanuja Ganu: So yes, Sridhar, that's very true. We are working on a very diverse set of projects right now. And, um, so to give a flavor of our work, I would discuss about two or three projects briefly. The first project is called HAMS that is Harnessing Automobiles for Safety. We all know that road safety is very critical issue and according to World Bank Report globally there are 1.25 million road traffic deaths every year. In India there is one death every 4 minutes. That happens due to road accidents. So, to understand and address this very critical issue of road safety, HAMS project was initiated by our team at MSR, including Venkat Padmanabhan, Akshay Nambi and Satish Sangameswaran. HAMS provides a low cost solution which is being evaluated for automated driver license testing. HAMS includes a smartphone with its associated sensors like camera, accelerometer, etc that is fitted inside a car. It monitors a driver and the driving environment and using AI and edge intelligence, it provides effective feedback on the safe driving practices. So at present, HAMS has been deployed at regional transport office in Dehradun, India for conducting dozens of driver license tests a day, and the feedback from this deployment is very encouraging, since it provides transparency and objectivity to the overall license testing and evaluation process. The second project is in the domain of natural language processing, called Interactive Neural Machine Translation, which was initiated by Kalika Bali and Monojit Choudhury in our NLP team. So, when we look at this problem, there are 7000 plus spoken languages worldwide, and for many many use cases, we often need to translate content from one language to another. Though there are many commercial machine translation tools available today, those are applicable to a very small subset of languages, say 100, which have sufficiently large digital datasets available to train machine learning models. So to aid human translation process as well as for creating digital data set for many low resource or underserved languages, we combine innovations from deep learning and human computer interactions and bring human in the loop. So when we talk about INMT, the initial translation model is bootstrapped using small data set that is available for these languages. And then INMT provides quick suggestions for human translators while they are performing translations. And over time it also helps in creating larger digital datasets which would help in increasing accuracy of translation for such underserved languages. So in INMT we're currently working with three external collaborators called Pratham Books, Translators Without Borders and CGNet Swara to evaluate and enhance INMT. So just to give few examples, Pratham Books is a nonprofit publisher who would like to translate children story books in as many languages as possible. Translators Without Borders is a nonprofit who is working in the areas of crisis relief, health and education, and they would like to evaluate IN&MT for an Ethiopian language called Tigrinya. Our other collaborator CGNet Swara is working with INMT for collecting Hindi Gondi data set. And just to give you one last flavor of one more project… Sridhar Vedantham: So I'm sorry, sorry to interrupt, but I was curious, how do you actually go around selecting or identifying partners and collaborators for these projects? Tanuja Ganu: So when we started thinking about SCAI projects last year, we had initiated a call for proposals where we invited external partners and collaborators to submit various ideas that they do have and the process that they have in addressing some of the societal impact projects and we Interestingly received a huge pool of applications through this call for proposals we received more than 150 applications through that. And through careful evaluation process, as we discussed earlier, we finally selected a few projects to start under SCAI umbrella. Sridhar Vedantham: OK, so I'm sorry I interrupted. You wanted to…you were speaking about another project. Tanuja Ganu: Yeah, so just to give one more flavor of the project that we are currently doing which is addressing another important issue of air pollution. So air pollution is another major concern worldwide, with an estimated 7 million deaths every year, and when we look in India, it's even more serious problem since 13 out of 20 most polluted cities in the world are in India. So to solve the air pollution problem, it is important to get correct monitoring of pollution levels, their timely and seasonal patterns in more granular manner, that is, from multiple locations inside the city. So apart from sophisticated and expensive air pollution monitoring stations feature already available, there are low-cost air pollution sensors which are being deployed for this purpose. But the local sensors tend to drift or develop fault overtime and the entire monitoring and analytical insights are dependent on reliability and correctness of this IoT data. So taking these things into account, we are now evaluating our research project called Dependable IoT for these low-cost air pollution sensors. Dependable IoT helps in automatically identifying and validating the drift or malfunction in the sensors and notifies for recalibration or replacement. So currently we are working with a few startups in this space to evaluate dependable IoT Technology and as the project name such as this is not only limited to air pollution sensing, but this technology is applicable for many other use cases for IoT sensing- in agriculture, food technology or in healthcare. So I guess this gives you a view on some of the diverse projects that now we are doing and working on at present in SCAI. Sridhar Vedantham: Yeah, so this Dependable IoT thing sounds quite interesting. So correct me if I'm wrong, but essentially, what we're saying is that we're trying to figure out ways in which we can ensure that the data that we're receiving in order to extract information from it and make decisions- we're actually trying to figure out our trying to make sure that the data itself is solid. Tanuja Ganu: Absolutely. That's correct, Sridhar, and it's like monitoring the monitor, right? So while we're doing the IoT monitoring and sensing, we need to make sure that the technology that we're putting in place is being monitored and it's giving us reliable and correct data. Sridhar Vedantham: Great. Now what's also coming across to me throughout this conversation is that given the variety of projects and the variety of collaborators that you're looking at in SCAI- would I be right in saying that the kind of people that you have in SCAI in addition to the researchers, obviously who are your internal collaborators, the people who are part of SCAI, are they a very diverse and varied set of people? Tanuja Ganu: Yes, absolutely true, Sridhar. As we discussed earlier, SCAI’s an interdisciplinary team that consists of social scientists, CS researchers, solid software engineers and designers. And we also have a program called SCAI Fellows where fresh under graduates or the candidates who are already working in the industry can join on the specific SCAI project for a fixed time period and contribute towards the development of SCAI project. So particularly in SCAI, in addition to all these technical or academic skills, we're also looking for people who have passion for societal impact and willingness to do the field work and deployment to scale a research idea. Sridhar Vedantham: OK, and you know, you might at any point of time be working on say, four, five or six projects. Uh, what happens to these projects once they are completed? Tanuja Ganu: Yeah, so I would say each project would have a different graduation plan. So whenever a project is complete from the SCAI perspective, we call it as a graduation plan where we would define how this project would then sustainably grow further internally or externally. And this graduation plan would be different for different projects depending upon the nature of the project. So for some of the projects, the graduation plan could be an independent entity that is spun off to take the journey of the project forward by scaling the initial idea to more people, more geographies, or for more use cases. A very good example of this type of graduation plan is a MSR project called 99 DOTS, where researchers like Bill Thies and others at Microsoft Research started this project to address medical adherence for tuberculosis. Over the years, this work has significantly grown and there is an independent entity spun off called Everwell to take the 99 DOTS journey forward. The other type of graduation plan can be putting up a work and technology in the open source wherein the external social enterprises, NGOs or our collaborators can build on top of it and take the solution forward at larger scale. The example of this is our work on interactive machine translation, where we have open sourced our initial work and various collaborators are now using, validating and building on top of this technology. Sridhar Vedantham: OK, and does the work that you do in SCAI or say the validation that you're looking for from research projects or the validation you're looking at of research projects through SCAI- does that feed back further into the research itself, or does it kind of just stay at SCAI? Tanuja Ganu: So, it has two or I would say it would have multiple pathways, but primarily the first thing is certainly the work that we're doing is validating certain research hypothesis that we do have. So some of the output or outcome of these SCAI projects is feeding back into the research areas and validating or invalidating the hypothesis to say how the technology is helping to solve a particular research problem or not. But also if the intervention is successful, it would be useful for external collaborators internally, externally for them to take up this idea forward and utilize the technology that we have built at SCAI to taking it to larger scale. Sridhar Vedantham: OK, so once again coming back to the fact that the projects that you do are of such different nature, how do you actually even define success metrics for SCAI projects? Tanuja Ganu: Yeah, this is a very interesting question, Sridhar. So, the whole purpose of SCAI, as the name suggests, is about bringing social impact through technology innovations. So there is no one fixed set of metrics that would be applicable for each and every project at SCAI. But our success metrics for these projects are geared towards validating whether technological interventions can support the people and ecosystem and actually help address a specific problem or not. And if it does help solve the problem, then how can we amplify the positive effect using technology? So those are really the metrics that we're defining on each of the project depending upon nature of the project. Sridhar Vedantham: So Tanuja, thank you so much for your time. This has been a great conversation and all the best for going forward in SCAI. Tanuja Ganu: Thank you, Sridhar, for having me here and I really enjoyed discussing these projects and ideas with you. Thank you. [Music Ends]
We discuss cardiogenic shock and decision making in the case of a young female presenting to the ER. We have a panel of cardiologists guide the discussion. Drs Rene Alvarez, Daniel Sims and Alec Vishnevski discuss the case presented by cardiology fellow Rachna Kataria, MD. Thanks for listening. Please like, subscribe and give us a rating.
We discuss the various aspects of cardiogenic shock including definition, heterogeneity, classification and management with an internationally renowned expert in the field Dr Navin Kapur. Dr Kapur is the Director of the Acute Mechanical Circulatory Support Program at Tufts University School of Medicine, Boston, MA. Listen, like, subscribe, and give us a high rating.
COVID-19 causes STEMI’s, arrhythmias and myocarditis?!? Emergency medicine and cardiology guru Amal Mattu, MD chats with Mizuho Morrison, DO on the cardiovascular effects of COVID-19. They discuss: the known pathophysiology of how viral infections affect the heart; Review the new consensus statement from the Society of Cardiovascular Angiography and interventions (SCAI), American College of Cardiology (ACC), and the American College of Emergency Physicians (ACEP) on how to manage STEMIs; and lastly discuss how cardiac arrest management differs in this COVID era. To view the references and show notes from this podcast Click here
COVID-19 causes STEMI’s, arrhythmias and myocarditis?!? Emergency medicine and cardiology guru Amal Mattu, MD chats with Mizuho Morrison, DO on the cardiovascular effects of COVID-19. They discuss: the known pathophysiology of how viral infections affect the heart; Review the new consensus statement from the Society of Cardiovascular Angiography and interventions (SCAI), American College of Cardiology (ACC), and the American College of Emergency Physicians (ACEP) on how to manage STEMIs; and lastly discuss how cardiac arrest management differs in this COVID era. To view the references and show notes from this podcast Click here
COVID-19 causes STEMI’s, arrhythmias and myocarditis?!? Emergency medicine and cardiology guru Amal Mattu, MD chats with Mizuho Morrison, DO on the cardiovascular effects of COVID-19. They discuss: the known pathophysiology of how viral infections affect the heart; Review the new consensus statement from the Society of Cardiovascular Angiography and interventions (SCAI), American College of Cardiology (ACC), and the American College of Emergency Physicians (ACEP) on how to manage STEMIs; and lastly discuss how cardiac arrest management differs in this COVID era. To view the references and show notes from this podcast Click here
COVID-19 causes STEMI’s, arrhythmias and myocarditis?!? Emergency medicine and cardiology guru Amal Mattu, MD chats with Mizuho Morrison, DO on the cardiovascular effects of COVID-19. They discuss: the known pathophysiology of how viral infections affect the heart; Review the new consensus statement from the Society of Cardiovascular Angiography and interventions (SCAI), American College of Cardiology (ACC), and the American College of Emergency Physicians (ACEP) on how to manage STEMIs; and lastly discuss how cardiac arrest management differs in this COVID era. Promo code for 3 month trial of ERcast in intro segment Hippo education COVID resource site: Link References: Mahjid, M. Payam, S. et al. Potential Effects of Coronaviruses on the Cardiovascular System: A Review [published online ahead of print, 2020 Mar 27]. JAMA Cardiol. PMID 32219363 Mahmud E, Dauerman HL, et al. Management of Acute Myocardial Infarction During the COVID-19 Pandemic,CONSENSUS STATEMENT from the Society of cardiovascular angiography and interventions (SCAI), American College of Cardiology (ACC), and the American College of Emergency Physicians (ACEP). Journal of the American College of Cardiology (2020), doi https://doi.org/10.1016/j.jacc.2020.04.039. PMID:32330544 Edelson D, Sasson C. et al. Interim Guidance for Basic and Advanced Life support in Adults, Children and Neonates with suspected or confirmed COVID-19. Circulation AHA April 2020. PMID: 32270695 Stefanini GG, Azzolini E, et al. Critical Organizational Issues for Cardiologists in the COVID-19 Outbreak: A Frontline Experience From Milan, Italy [published online ahead of print, 2020 Mar 24]. Circulation 2020. PMID: 32207994
This month features news from the latest spate of cardiology meetings: SCAI, EuroPCR, HRS, and more.
Dr. Ehtisham Mahmud, Division Chief of Cardiovascular Medicine at UC San Diego and the incoming president of the Society of Cardiovascular Angiography and Interventions (SCAI), discusses cutting edge research presented at the SCAI 2019 scientific sessions, new trends in interventional cardiology, and new devices and techniques being used to increase cardiac health for all patients. Visit www.hpr.fm to listen to more interviews about healthcare and research findings.
This month features news from the latest spate of cardiology meetings: SCAI, EuroPCR, HRS, and more.
You can find more of our podcasts on our website: http://www.mdedge.com/podcasts This week in cardiology news: SCAI releases first definition of cardiogenic shock CABANA: Heart failure patients got biggest bang from AFib ablation Elderly concussion patients who used statins had lower dementia risk BMI in male teens predicts cardiomyopathy risk You can email the show at podcasts@mdedge.com and you can interact with us on Twitter at @MDedgeCardio.
In this edition of Device Week, Medtech Insight's Catherine Longworth chats with Marion Webb about Livongo's acquisition of behavioral health company myStrength and with Reed Miller about the controversy surrounding the meta-analysis finding of a higher mortality risk with paclitaxel-eluting peripheral devices. Listen to the podcast via the player below: For more information on Medtech Insight and to start a free trial, click here: http://bit.ly/2w7LnlR Medtech Insight articles addressing topics discussed in this episode: SCAI, Manufacturers Defend Peripheral Paclitaxel Devices Against Doubts Livongo Buys Behavioral Health Firm in Multimillion Dollar Deal, Plans to Hire 300-500 People
Seorang petani dan juga Ketua Koperasi Barokah, yang berfokus pada komoditas kopi arabica speciality yang bekerja sama dengan 250 petani. Koperasi Barokah telah mendapatkan penghargaan dan menjuarai beberapa kompetisi. 9th Indonesian Speciality Coffee Contest oleh AEKI. Pada tahun 2018, mendapatkan penghargaan Brozen Gourmet oleh Paris, juara 2 di KKSI oleh AEKI dengan nilai 90.44, juara 5 produk Honey dengan nilai 83.33 yang diselenggarakan oleh SCAI.
Dr. Ashok Seth and Dr. Srihari Naidu Discuss
Dr. Arnold Seto, Dr. Dean Boudoulas and Dr. C. Michael Gibson Discuss
Dr. David Cox and Dr. C. Michael Gibson Discuss
Dr. Adir Shroff and Dr. C. Michael Gibson Discuss
Dr. Emmanouil Brilakis, Dr. Sunil Rao and Dr. C. Michael Gibson Discuss
Dr. Rajesh Swaminathan, Dr. Dmitriy Feldman and Dr. C. Michael Gibson Discuss
Dr. Dmitriy Feldman and Dr. C. Michael Gibson Discuss
Dr. Kalon Ho and Dr. C. Michael Gibson Discuss
Dr. Kenneth Rosenfield and Dr. C. Michael Gibson Discuss
Dr. Roxana Mehran and Dr. C. Michael Gibson Discuss
Jeff Davis, Bernadette Speiser, Rena Silver and Dr. C. Michael Gibson Discuss
Francesca Dea and Dr. C. Michael Gibson Discuss
I’m at the SCAI conference in New Orleans Louisiana this week. It’s the Society for Cardiovascular and Angiography Interventions. Basically, it’s a conference with a heavy focus on unclogging arteries. Why is this important? Cardiovascular disease is the #1 killer in the United States. Peripheral Artery Disease, which targets the peripherals, mainly the legs, impacts more than 50% of people over the age of 60. It used to be that invasive surgical procedures such as bypasses or even amputation were the go-to solutions. But advances in technology are such that now interventional cardiologists, with only a small hole in the body, not larger than a pencil eraser, can reach into the arteries with small devices to unclog blocked arteries and keep the blood flowing. At the forefront of cutting edge technology for cardiology is Dr. Ehtisham Mahmud, Chief of Cardiovascular Medicine for UC San Diego Health System. He is co-director of the SCAI Conference and always has the pulse on what’s new and what’s next. He’s one of the most sought after doctors in this space for new medical technology studies around the world, including the latest laser technology by Ra Medical Systems which uses photomolecular ablation much like is used in LASIK surgery for your eyes, to unclog arteries, and also he’s one of the first to be using robotics in his interventions. His colleague, who plays a critical role in key studies on new technologies at the University joins the second half of the show to share his insights as well. Dr. Mitul Patel is an Associate Clinical Professor of Medicine, Interventional Cardiology, Division of Cardiovascular Medicine, for the UC San Diego Health System. Listen to the show to hear Dr. Mahmud and Dr. Pitel talk about how doctors may be turning into gamers as a joystick is replacing their hands in the operating room, or as Interventional Cardiologists call it, the ‘Cath Lab’. Nearly 800 robotic procedures have been performed across the country. Dr. Mahmud shares late breaking news on the findings of the latest study, which spanned the country. He also discusses how a $3.1 million dollar grant is helping his team to discover new ways to heal tissue damage, caused by oxygen starvation because of lack of blood flow, using regenerative medicine. Plus, if you’re an entrepreneur who wants to innovate in the healthcare space, the doctors share what’s most important to them. Finally, you don’t want to miss their potentially life-saving advice for patients. Dr. Pitel shares the critical questions you should ask your doctor to ensure you are getting the most advanced care available, including new technology and techniques.
Dr. David Zhao, Dr. Luis Guzman and Dr. C. Michael Gibson Discuss
Dr. Kirk Garratt and Dr. C. Michael Gibson Discuss
Dr. Robert Applegate and Dr. C. Michael Gibson Discuss
Dr. Bernhard Meier, Dr. Joseph Babb, Dr. George Vetrovec, Dr. Spencer King and Dr. C. Michael Gibson Discuss
Commentary by Dr. Valentin Fuster
Commentary by Dr. Valentin Fuster
Commentary by Dr. Valentin Fuster
© 2020-2025 Ivy Podcast Discovery LLC
